12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Crispr Therapeutics Ag (CRSP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 10,165,400 | $345,928,566 | +14% | 3.46% |
| 2. | Bayforest Capital Theodoros Tsagaris | 12,424 | $243,553 | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.85 | 7,000 | 7,000 | 2025-02-26 | Filing | ||
| $24.95 | 27,461 | Large Shareholder | 5,380,940 | 2018-12-27 | Filing | |
| $24.89 | 12,737 | Large Shareholder | 5,353,479 | 2018-12-26 | Filing | |
| $24.97 | 53,655 | Large Shareholder | 5,340,742 | 2018-12-24 | Filing | |
| $23.18 | 11,742 | Large Shareholder | 5,287,087 | 2018-12-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.23 | 10,031 | 195,085 | 2025-03-21 | Filing | ||
| $41.23 | 1,714 | 10,544 | 2025-03-21 | Filing | ||
| $41.23 | 2,197 | 16,767 | 2025-03-21 | Filing | ||
| $41.23 | 3,185 | 81,729 | 2025-03-21 | Filing | ||
| $41.80 | 3,762 | 12,714 | 2025-03-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,613,539 | $88,938,732 | 0% | |
| 2. | 2,539,889 | $86,432,423 | 0.06% | |
| 3. | 2,539,889 | $86,330,827 | 1.11% | |
| 4. | 1,769,709 | $60,223,198 | 0% | |
| 5. | 713,539 | $24,281,732 | 0% |
News See All
CRISPR Therapeutics AG (CRSP): A Bull Case Theory
We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this article, we will summarize the bulls’ thesis on CRSP.
12 Most Shorted Stocks in 2025
Reuters reported that President Trump’s tariffs have impacted the broader stock markets, weighing on investors’ sentiments, as worries related to the economic slowdown drove a market sell-off which...
Ark Invest Stock Portfolio: Top 10 Stocks to Buy
ARK Investment Management LLC, commonly known as ARK Invest, is an American investment management firm headquartered in St. Petersburg, Florida.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity...
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that healthcare spending in the US reached $4.9 trillion in 2023, up 7.5% from 2022.
Cathie Wood's Stock Portfolio: 2025 Stock Picks
Cathie Wood is one of Wall Street's most contentious figures.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.